Evidence map›Paper›PMID 33034087›Full record

ArticleJournal of intellectual disability research : JIDR2020

Development, behaviour and sensory processing in Marshall-Smith syndrome and Malan syndrome: phenotype comparison in two related syndromes.

P A Mulder, I D C van Balkom, A M Landlust, M Priolo, L A Menke, I H Acero, F S Alkuraya, P Arias, L Bernardini, E K Bijlsma and 48 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of intellectual disability research : JIDR, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. [Nuclear Factor I-X Regulates Molecular Pathways Related to Craniofacial Development Through Phase Separation].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Remote monitoring of social attention in neurogenetic syndromes and idiopathic neurodevelopmental disability.Autism research : official journal of the International Society for Autism Research · 2025
    Article
  9. Article
  10. Mechanistic insights intoFrontiers in genetics · 2025
    Article
  11. Article
  12. Review
  13. [Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Behavioral profiling in children and adolescents with Malan syndrome.Frontiers in child and adolescent psychiatry · 2023
    Article
  18. Sensory processing in 16p11.2 deletion and 16p11.2 duplication.Autism research : official journal of the International Society for Autism Research · 2022
    Article
  19. Article
  20. Hydrocephalus inCells · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

58 authors at 20 institutions in 14 countries.

P A MulderAutism Team Northern-Netherlands, Jonx Department of (Youth) Mental Health and Autism, Lentis Psychiatric Institute, Groningen, Netherlands.ORCID 0000-0001-9489-4022
I D C van BalkomAutism Team Northern-Netherlands, Jonx Department of (Youth) Mental Health and Autism, Lentis Psychiatric Institute, Groningen, Netherlands.
A M LandlustAutism Team Northern-Netherlands, Jonx Department of (Youth) Mental Health and Autism, Lentis Psychiatric Institute, Groningen, Netherlands.
M PrioloUnità Operativa di Genetica Medica, Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Reggio Calabria, Italy.
L A MenkeDepartment of Paediatrics, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
I H AceroGenetics Unit, Hospital Universitario Central de Asturias, Oviedo, Spain.
F S AlkurayaSaudi Human Genome Project, King Abdulaziz City for Science and Technology, and Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
P AriasInstitute of Medical and Molecular Genetics (INGEMM), Hospital Universitario La Paz, IdiPAZ, Universidad Autónoma de Madrid, and CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII, Madrid, Spain.
L BernardiniCytogenetics Unit, Casa Sollievo della Sofferenza Foundation, San Giovanni Rotondo, Italy.
E K BijlsmaDepartment of Clinical Genetics, Leiden University Medical Centre, Leiden, Netherlands.
T ColeDepartment of Clinical Genetics, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
C CoubesDépartement de Génétique Médicale, Hôpital Arnaud de Villeneuve, CHRU Montpellier, Montpellier, France.
I DapiaInstitute of Medical and Molecular Genetics (INGEMM), Hospital Universitario La Paz, IdiPAZ, Universidad Autónoma de Madrid, and CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII, Madrid, Spain.
S DaviesInstitute of Medical Genetics, University Hospital of Wales, Cardiff, UK.
N Di DonatoInstitute for Clinical Genetics, TU Dresden, Dresden, Germany.
N H ElciogluDepartment of Pediatric Genetics, Marmara University Medical School, Istanbul and Eastern Mediterranean University, Mersin, Turkey.
J A FahrnerMcKusick-Nathans Institute of Genetic Medicine, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
A FosterInstitute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
N G GonzálezUnit Hospital Universitario Central de Asturias, Oviedo, Spain.
I HuberSørland Hospital, Kristiansand, Norway.
M IasconeMedical Genetics Laboratory, ASST Papa Giovanni XXIII, Bergamo, Italy.
A-S KaiserInstitute of Human Genetics, Heidelberg University, Heidelberg, Germany.
A KamathInstitute of Medical Genetics, University Hospital of Wales, Cardiff, UK.
K KooblallAcademic Endocrine Unit, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
P LapunzinaInstitute of Medical and Molecular Genetics (INGEMM), Hospital Universitario La Paz, IdiPAZ, Universidad Autónoma de Madrid, and CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII, Madrid, Spain.
J LiebeltSouth Australian Clinical Genetics Services, Women's and Children's Hospital, North Adelaide, Australia.
S A LynchUCD Academic Centre on Rare Diseases, School of Medicine and Medical Sciences, University College Dublin, and Clinical Genetics, Temple Street Children's University Hospital, Dublin, Ireland.
S M MaasDepartment of Clinical Genetics, Academic Medical Center, Amsterdam, Netherlands.
C MammìUnità Operativa di Genetica Medica, Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Reggio Calabria, Italy.
I B MathijssenDepartment of Clinical Genetics, Academic Medical Center, Amsterdam, Netherlands.
S McKeeNorthern Ireland Regional Genetics Service, Belfast Health and Social Care Trust, Belfast, UK.
G M MirzaaCenter for Integrative Brain Research, Seattle Children's Research Institute, and Division of Genetic Medicine, University of Washington School of Medicine, Seattle, WA, USA.
T MontgomeryNewcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne, UK.
D NeubauerInstitute of Human Genetics, University Hospital Magdeburg, Magdeburg, Germany.
T E NeumannMitteldeutscher Praxisverbund Humangenetik, Halle, Germany.
L PintomalliUnità Operativa di Genetica Medica, Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Reggio Calabria, Italy.
M A PisantiMedical Genetic and Laboratory Unit, "Antonio Cardarelli" Hospital, Naples, Italy.
A S PlompDepartment of Clinical Genetics, Academic Medical Center, Amsterdam, Netherlands.
S PriceDepartment of Clinical Genetics, Northampton General Hospital NHS Trust, Northampton, UK.
C SalterWessex Clinical Genetics Service, Princess Ann Hospital, Southampton, UK.
F Santos-SimarroInstitute of Medical and Molecular Genetics (INGEMM), Hospital Universitario La Paz, IdiPAZ, Universidad Autónoma de Madrid, and CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII, Madrid, Spain.
P SardaDépartement de Génétique Médicale, Hôpital Arnaud de Villeneuve, CHRU Montpellier, Montpellier, France.
D SchanzeInstitute of Human Genetics, University Hospital Magdeburg, Magdeburg, Germany.
M SegoviaCENAGEM, Centro Nacional de Genética, Buenos Aires, Argentina.
C Shaw-SmithRoyal Devon and Exeter NHS Foundation Trust, Exeter, UK.
S SmithsonUniversity Hospitals Bristol NHS Trust, Bristol, UK.
M SuriNottingham Clinical Genetics Service, Nottingham University Hospitals NHS Trust, Nottingham, UK.
K Tatton-BrownDivision of Genetics and Epidemiology, Institute of Cancer Research, London and South West Thames Regional Genetics Service, St. George's University Hospitals NHS Foundation Trust, London, UK.
J TenorioInstitute of Medical and Molecular Genetics (INGEMM), Hospital Universitario La Paz, IdiPAZ, Universidad Autónoma de Madrid, and CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII, Madrid, Spain.
R V ThakkerAcademic Endocrine Unit, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
R M ValdezGenetics Unit, Hospital Militar Central "Cirujano Mayor Dr. Cosme Argerich", Buenos Aires, Argentina.
A Van HaeringenDepartment of Clinical Genetics, Leiden University Medical Centre, Leiden, Netherlands.
J M Van HagenDepartment of Clinical Genetics, VU University Medical Centre, Amsterdam, Netherlands.
M ZenkerInstitute of Human Genetics, University Hospital Magdeburg, Magdeburg, Germany.
M ZollinoDepartment of Laboratory Medicine, Institute of Medical Genetics, Catholic University, Rome, Italy.
W W DunnDepartment of Occupational Therapy Education, School of Health Professions, University of Missouri, Columbia, MO, USA.
S PieningAutism Team Northern-Netherlands, Jonx Department of (Youth) Mental Health and Autism, Lentis Psychiatric Institute, Groningen, Netherlands.
R C HennekamAutism Team Northern-Netherlands, Jonx Department of (Youth) Mental Health and Autism, Lentis Psychiatric Institute, Groningen, Netherlands.
Hospital Universitario La Paz · ESAmsterdam UMC Location University of Amsterdam · NLAzienda ospedaliera "Bianchi-Melacrino-Morelli" · ITLentis · NLUniversity Hospital Magdeburg · DEHôpital Arnaud de Villeneuve · FRHospital Universitario Central de Asturias · ESJohn Radcliffe Hospital · GBLeiden University Medical Center · NLUniversity Hospital of Wales · GBUniversity Medical Center Groningen · NLAllen Institute for Brain Science · USAmsterdam Neuroscience · NLAmsterdam UMC Location Vrije Universiteit Amsterdam · NLArgerich Hospital · ARBelfast Health and Social Care Trust · GBBirmingham Women’s and Children’s NHS Foundation Trust · GBCasa Sollievo della Sofferenza · ITCatholic University of America · USEastern Mediterranean University · CY

Funding

Mechanisms of Brain Dysmorphology in MN1 C-Terminal Truncation Syndrome, a Novel Intellectual Developmental Disability Disorder P50HD103524 · NICHD · UNIVERSITY OF WASHINGTON · PI Sandra E Juul · 2020 to 2026
$9.9M
Genes and pathways underlying brain overgrowth and focal cortical malformationsK08NS092898 · NINDS · SEATTLE CHILDREN'S HOSPITAL · PI MIRZAA, GHAYDA · 2015 to 2019
$930k
NICHD NIH HHS P50 HD103524NINDS NIH HHS K08 NS092898NINDS NIH HHS K08NS092898
6 · The paper itself

Abstract

backgroundUltrarare Marshall-Smith and Malan syndromes, caused by changes of the gene nuclear factor I X (NFIX), are characterised by intellectual disability (ID) and behavioural problems, although questions remain. Here, development and behaviour are studied and compared in a cross-sectional study, and results are presented with genetic findings.

methodsBehavioural phenotypes are compared of eight individuals with Marshall-Smith syndrome (three male individuals) and seven with Malan syndrome (four male individuals). Long-term follow-up assessment of cognition and adaptive behaviour was possible in three individuals with Marshall-Smith syndrome.

resultsMarshall-Smith syndrome individuals have more severe ID, less adaptive behaviour, more impaired speech and less reciprocal interaction compared with individuals with Malan syndrome. Sensory processing difficulties occur in both syndromes. Follow-up measurement of cognition and adaptive behaviour in Marshall-Smith syndrome shows different individual learning curves over time.

conclusionsResults show significant between and within syndrome variability. Different NFIX variants underlie distinct clinical phenotypes leading to separate entities. Cognitive, adaptive and sensory impairments are common in both syndromes and increase the risk of challenging behaviour. This study highlights the value of considering behaviour within developmental and environmental context. To improve quality of life, adaptations to environment and treatment are suggested to create a better person-environment fit.

Indexed as

Abnormalities, MultipleAdaptation, PsychologicalAdolescentAdultBone Diseases, DevelopmentalChildChild, PreschoolComorbidityCraniofacial AbnormalitiesCross-Sectional StudiesFemaleFollow-Up StudiesHumansIntellectual DisabilityMaleMental Disordersadaptive behaviourcognitionMalan syndromeMarshall-Smith syndromeNFIX variantssensory processing

Identifiers

PMID33034087
PMCPMC8957705
OpenAlexW3092360474

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.